Conteduca, Vincenza
Scarpi, Emanuela
Salvi, Samanta
Casadio, Valentina
Lolli, Cristian
Gurioli, Giorgia
Schepisi, Giuseppe
Wetterskog, Daniel
Farolfi, Alberto
Menna, Cecilia
De Lisi, Delia
Burgio, Salvatore Luca
Beltran, Himisha
Attard, Gerhardt
De Giorgi, Ugo
Article History
Received: 30 January 2018
Accepted: 4 October 2018
First Online: 18 October 2018
Competing Interests
: V.C. and U.D.G. have received speaker honoraria or travel support from Astellas, Janssen-Cilag and Sanofi- Aventis. V.C. has received consulting fees from Bayer. G.A. has received commercial research grants from Janssen, Arno Therapeutics, and Innocrin Pharma, has received honoraria from the Speakers Bureaus of Janssen, Astellas, Sanofi-Aventis, and Roche/Ventana, has ownership interest (including patents) in The Institute of Cancer Research Rewards to Inventors, and is a consultant/advisory board member for Janssen-Cilag, Veridex, Bayer Healthcare, Roche/Ventana, Astellas, Medivation, Pfizer, Novartis, Millennium Pharma, Abbott Laboratories, and Essa Pharma. No potential conflicts of interest were disclosed by the other authors.